MedPath
NMPA Approval

Rizatriptan Monobenzoate Tablets

国药准字H20143331

January 16, 2024

Drug Information

苯甲酸利扎曲普坦片

片剂

5mg(以C15H19N5计)

化学药品

January 16, 2024

Company Information

Applicant Company

山东省菏泽市牡丹区中华西路369号

Manufacturing Company

山东省菏泽市牡丹区中华西路369号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

苯甲酸利扎曲普坦片 - NMPA 批准文号 | MedPath